Merlin (MRLN) Market Update – 22 October 2026
- Closing price: USD 0.93
- 24‑hour change: down 6.67 % (end time 03:40 PM Central Europe, Thursday)
- Shares outstanding: 101.1 million
- Market capitalization: USD 106.1 million
- Volume in last 24 h: USD 3.1 million worth of shares traded
- Month‑to‑date performance: down 48.96 % since the end of the previous month
- 200‑day simple moving average: USD 6.84
- 52‑week high: USD 17 (16 April 2026)
- 52‑week low: USD 0.98 (21 October 2026)
Peer Performance – 24 Hours
| Ticker | Change | Current Price | Market Capitalization | Notes |
|---|---|---|---|---|
| MED (Medifast) | +0.33 % | USD 12.21 | USD 124.7 million | — |
| BOTJ (Bank Of The James) | +1.24 % | USD 28.12 | USD 125.1 million | P/E 10.79; operating results improved over first nine months; EPS and ROE rose; net interest and fee income increased; costs controlled; capital ratios above thresholds; assets under management higher; customer satisfaction above peers; no adverse events reported |
| OTLK (Outlook Therapeutics) | +7.88 % | USD 0.56 | USD 126.6 million | — |
| PGDC.V (Patagonia Gold) | -2.56 % | CAD 0.38 | CAD 178.5 million | — |
| MGYR (Magyar) | -0.46 % | USD 19.39 | USD 125.8 million | P/E 10.54 |
Summary
Merlin experienced a significant decline in the 24‑hour period, falling 6.67 % to USD 0.93 per share, with a trading volume of USD 3.1 million. The company’s market capitalization stands at USD 106.1 million, based on 101.1 million shares outstanding. Over the month‑to‑date period, the stock has dropped 48.96 %. Its price remains well below the 200‑day moving average of USD 6.84, and its 52‑week range is USD 0.98–USD 17.
Peer companies showed varied movements, with Outlook Therapeutics registering the largest gain at 7.88 %, while Patagonia Gold declined 2.56 %. Bank Of The James posted modest gains and highlighted improved operating metrics and robust capital ratios in its latest financial update.
